Polaris Partners — 2024 Investments
5 investments dated 2024 · listed companies and verified rows first · show all
Epibiologics develops protein degradation medicines using protein sciences and antibody engineering capabilities.
BiotechMedical DevicesSan Mateo, US
Ann Lee-Karlon(Executive Officer, Director)Mitchell Mutz(Executive Officer, Director)James Wells(Director)
BoardSamuel Bjork(Director)Seiji Miyahara(Director)
Board seatAlexandra Cantley· per SEC Form D · $73M raise · filed Apr 2024
Co-investorsAvego BioScience CapitalGV (Google Ventures)Mission BiocapitalNovartis Venture FundRoche Venture FundSamsara BioCapital+3 more
Noetik builds AI models to identify cancer patients most likely to respond to treatments and to discover new oncology drug targets.
AI & Machine LearningBiotechHealthtechSouth San Francisco, US
Jacob Rinaldi(Executive Officer, Director, Promoter)Ronald Alfa(Executive Officer, Director, Promoter)Ron Alfa, MD, PhD(Founder)in
BoardJames Hardiman(Director)in
Board seatAmy Schulman· per SEC Form D · $40M raise · filed Aug 2024
Co-investors11.2 CapitalBreakout VenturesLinearis VenturesNorth South VenturesDCVC (Data Collective)
Seismic Therapeutic is a clinical-stage biotechnology company that uses machine learning to discover and develop immunology therapies for autoimmune diseases.
AI & Machine LearningBiotechDeep TechMedical DevicesBoston, US
JoTimothy A. Springer(Scientific Advisor / Founder)Kevin(Head of Immunology and Biomarker)Jo Viney, PhD(Founder, President and Chief Executive Officer)Alan Crane(Founder and Chairman of Seismic Therapeutic; Polaris Partners)Tim Springer, PhD(Founder of Seismic Therapeutic; Harvard Medical School and Boston Children's Hospital)
Board seatAlan Crane· per SEC Form D · $146.3M raise · filed Sep 2024
Co-investorsBessemer Venture PartnersGV (Google Ventures)Mana Ventures
BiotechSouth San Francisco, US
M. Johnston Erwin Jr.(Executive Officer, Director)
BoardEric Pham(Director)Travis Coy(Director)Carol Gallagher(Director)Joel Marcus(Director)Michael Ross(Director)
Board seatAlexandra Cantley· per SEC Form D · $85M raise · filed Nov 2024
Baxter Planning provides software and services for service supply chain management, serving enterprises managing complex operational logistics and supplier networks.
AI & Machine LearningEnterprise SoftwareLogistics & Supply ChainSaaS
Anton Chilton(Chief Executive Officer)in
Co-investorsGolub GrowthMarlin Equity Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.